USPTO to appeal claims and continuations case
In the latest round of GlaxoSmithKline’s and inventor Triantafyllos Tafas’s battle to stop the USPTO from introducing new rules on patent claims and continuations, the USPTO yesterday said it planned to appeal a court decision that gave victory to its opponents last month
The Office officially filed a Notice of Appeal with the Court of Appeals for the Federal Circuit.
In a decision last month, Judge James Cacheris of the District Court for the Eastern District of Virginia granted GSKs and Tafas motion...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.